Table 3.
Immunosuppression use, by diagnosisa
| IgAN n = 506 |
IgAV n = 161 |
P value | |
|---|---|---|---|
| n (%) | n (%) | ||
| Number of medication classes usedb | |||
| 0 | 232 (46.0%) | 33 (20.5%) | <0.001 |
| 1 | 169 (33.5%) | 71 (44.1%) | |
| 2 | 77 (15.3%) | 49 (30.4%) | |
| 3 | 23 (4.6%) | 5 (3.1%) | |
| 4 | 3 (0.6%) | 3 (1.9%) | |
| Medication class | |||
| Cyclophosphamide | 22 (4.3%) | 17 (10.6%) | 0.004 |
| Azathioprine | 22 (4.3%) | 13 (8.1%) | 0.07 |
| Mycophenolate mofetil | 61 (12.1%) | 28 (17.4%) | 0.09 |
| Corticosteroids | 257 (50.8%) | 124 (77.0%) | <0.001 |
| RAAS blockade | 411 (81.2%) | 113 (70.2%) | 0.002 |
a
Immunosuppression use at or before enrollment visit.
b
Missing medication data for 2 patients.